{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:47Z","timestamp":1791223547337,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Walter Reed Army Institute of Research (WRAIR), USA"},{"name":"National Vaccine Program (NVP), USA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.10.035","type":"journal-article","created":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T04:16:43Z","timestamp":1288498603000},"page":"1347-1354","source":"Crossref","is-referenced-by-count":65,"title":["Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh"],"prefix":"10.1016","volume":"29","author":[{"given":"Kazi Mizanur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shams El","family":"Arifeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbubur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubhana","family":"Raqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Yunus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazma","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shaheenul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrul Munir","family":"Sohel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muntasirur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malabi","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Isenbarger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J.","family":"Sansonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah H.","family":"Baqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2010.10.035_bib0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/infdis\/161.3.500","article-title":"Death in shigellosis: incidence and risk factors in hospitalized patients","volume":"161","author":"Bennish","year":"1990","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2010.10.035_bib0010","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.035_bib0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/infdis\/166.4.792","article-title":"Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age","volume":"166","author":"Baqui","year":"1992","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2010.10.035_bib0020","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1371\/journal.pmed.0030353","article-title":"A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology","volume":"3","author":"von Seidlein","year":"2006","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.035_bib0025","first-page":"201","article-title":"Molecular mechanisms of cell and tissue invasion by Shigella flexneri","volume":"2","author":"Sansonetti","year":"1993","journal-title":"Infect Agents Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2010.10.035_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/IAI.66.1.77-82.1998","article-title":"Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602","volume":"66","author":"Barzu","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.035_bib0035","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","article-title":"Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers","volume":"72","author":"Katz","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.10.035_bib0040","unstructured":"ICDDRB, Health and Demographic Surveillance System- Matlab: Registration of Demographic Events and Contraceptive Use 1998. Dhaka, Bangladesh; 2000."},{"key":"10.1016\/j.vaccine.2010.10.035_bib0045","series-title":"ASTM&H Conference Proceedings","article-title":"Detection of PCR products of the ipaH gene from Shigella and enteroinvasive Escherichia coli by enzyme linked immunosorbent assay","author":"Sethabutr","year":"1998"},{"key":"10.1016\/j.vaccine.2010.10.035_bib0050","first-page":"51","article-title":"Future needs and directions for Shigella vaccines","volume":"81","author":"WHO","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.035_bib0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-3083.2002.01079.x","article-title":"Delayed and reduced adaptive humoral immune responses in children with shigellosis compared with in adults","volume":"55","author":"Raqib","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2010.10.035_bib0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0888-0786(93)90023-S","article-title":"Immune responses to Shigella dysenteriae type 1 and Shigella flexneri lipopolysaccharide and polysaccharide antigens in Bangladeshi patients with shigellosis","volume":"1","author":"Raqib","year":"1993","journal-title":"Serol Immun Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.035_bib0065","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/IAI.65.6.2107-2111.1997","article-title":"Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers","volume":"65","author":"Sack","year":"1997","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2010.10.035_bib0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.10.035_bib0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0264-410X(02)00348-1","article-title":"Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children","volume":"21","author":"Hallander","year":"2002","journal-title":"Vaccine"},{"issue":"8546","key":"10.1016\/j.vaccine.2010.10.035_bib0080","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(87)90649-0","article-title":"Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants","volume":"1","author":"Hanlon","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.035_bib0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.1980030305","article-title":"Immunisation against polioviruses in developing countries","author":"John","year":"1993","journal-title":"Rev Med Virol"},{"issue":"8821","key":"10.1016\/j.vaccine.2010.10.035_bib0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5\u20139-year-old Indonesian children","volume":"340","author":"Suharyono","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.035_bib0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ije\/19.3.711","article-title":"Efficacy of oral poliovirus vaccine in rural communities of North Arcot District, India","volume":"19","author":"Balraj","year":"1990","journal-title":"Int J Epidemiol"},{"issue":"9741","key":"10.1016\/j.vaccine.2010.10.035_bib0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T07:49:07Z","timestamp":1592034547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10015057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10015057"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}